Results 151 to 160 of about 384,620 (341)
Recently, there has been growing discussion about how to best assess pain in clinical trials in rheumatic diseases. Reliable measurement of pain outcomes is essential for accurately determining the effectiveness of treatments. Although pain intensity is the most common measure of change in pain trials, other pain‐related measures, such as pain ...
Yen T. Chen +4 more
wiley +1 more source
Effects of the Rheumatoid Factor and Antigen-Antibody Complexes on the Vessels of the Rat Mesentery [PDF]
John Baum, Peter Šťastný, Morris Ziff
openalex +1 more source
Rheumatoid factor and rheumatoid arthritis [PDF]
openaire +2 more sources
Autologous Agglutinators to Erythrocytes Sensitized with the Ripley Anti-Rh Antibody Digested with 14 Different Proteolytic Enzymes [PDF]
Studies with 14 different enzyme digested globulin preparations of a single anti-Rh serum Ripley has revealed an astonishing array of autoagglutinators to his enzymatically degraded anti-Rh antibodies.
Waller, Marion
core +1 more source
Knee crepitus and osteoarthritis features in young adults following traumatic knee injury
Objective This study explored the association between knee crepitus and the presence, and worsening, of structural osteoarthritis features and self‐reported outcomes in young adults following traumatic knee injury. Methods One‐year following anterior cruciate ligament reconstruction (ACLR), 112 participants (41 female participants; median age 28 years)
Jamon L Couch +8 more
wiley +1 more source
Protection of a Complement-Sensitive Enzyme System by Rheumatoid Factor [PDF]
JOHN STAIGE DAVIS, Alfred Jay Bollet
openalex +1 more source
Background/Aims Asymptomatic hyperuricemia is a precursor of gout and is also associated with cardiovascular disease and chronic kidney disease. The aim of this study was to understand perceptions about asymptomatic hyperuricemia and views about urate‐lowering therapy in people with asymptomatic hyperuricemia.
Nicola Dalbeth +19 more
wiley +1 more source
Effects of rheumatoid factor on complement levels in vivo [PDF]
William W. Gough, JOHN STAIGE DAVIS
openalex +1 more source
Objectives This study aimed to identify the frequency and determinants of Lupus Low Disease Activity State (LLDAS) and Definition of Remission in SLE (DORIS‐remission) attainment in systemic lupus erythematosus (SLE) patients with clinically active disease, and the frequency and determinants of flare and damage accrual after target attainment.
Yanjie Hao +39 more
wiley +1 more source
IntroductionTumor Necrosis Factor Alpha is a known pro-inflammatory cytokine that plays a key role in the pathogenesis of rheumatoid arthritis. Anti-cytokine therapies targeting Tumor Necrosis Factor Alpha have greatly succeeded in treating rheumatoid ...
Roman Perik-Zavodskii +22 more
doaj +1 more source

